GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Anadys Pharmaceuticals, Inc. (ANDS) [hlAlert]

Rating:
Hold ANDS
down 33.20 %

Anadys Pharmaceuticals, Inc. (ANDS) downgraded to Hold with price target $2 by ThinkEquity

Posted on: Friday,  Oct 15, 2010  8:25 AM ET by ThinkEquity

ThinkEquity rated Hold Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) on 10/15/2010. Previously ThinkEquity rated Buy Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) on 08/11/2009.,
when the stock price was $2.62. Since then, Anadys Pharmaceuticals, Inc. has lost 33.21% as of 10/15/2010's recent price of $1.75.
If you would have followed the previous ThinkEquity's recommendation on ANDS, you would have lost 33.2% of your investment in 430 days.

Anadys Pharmaceuticals, Inc., is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small molecule medicines for the treatment of viral diseases and cancer. The Company's programs focus on Toll-Like Receptor-based small molecule product candidates and direct antiviral compounds that inhibit key steps in viral proliferation. The Company has core expertise in medicinal chemistry coupled with structure-based drug design, and is developing compounds for the treatment of hepatitis C infection, hepatitis B infection and cancer.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/15/2010 8:25 AM Hold
None
1.75 2.00
as of 12/31/2010
1 Week   
1 Month   
3 Months down  -24.56 %
1 YTD down  -17.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/11/2009 11:25 AM Buy
None
2.62 4.00
7/31/2009 8:25 AM Buy
None
2.79 3.00
5/11/2009 8:25 AM Buy
None
2.48 6.00
3/16/2009 8:25 AM Buy
None
6.06 8.00
1/27/2009 8:25 AM Buy
None
4.80 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy